名稱 | BCR(E13)-ABL1(E2)_P210 Fusion |
型號 | CBP20207R |
報價 | ![]() |
特點 | BCR(E13)-ABL1(E2)_P210 Fusion |
產(chǎn)品搜索
相關(guān)文章
- 淺談NTRK fusion
- RNA-Fusion Cocktail再升級
- CYP2D6基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 購買細(xì)胞株前需要了解的相關(guān)技術(shù)知識
- IL-2藥物細(xì)胞篩選模型
- 自身免疫疾病潛力靶點——IL-5藥篩細(xì)胞模型
- Cell Metab:雙信號通路失調(diào)協(xié)同促進(jìn)肺癌形成
- 熱門CTLA4&PD1/L1雙靶點抗體活性檢測細(xì)胞模型
- eLife:為何肺癌靶向治療會失???看看科學(xué)家們怎么說
- 【連載-企業(yè)參考品】胃腸道間質(zhì)瘤的PCR和NGS參考品的選擇
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
電話:4008750250
號碼:
手機:18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
基因檢測標(biāo)準(zhǔn)品 > Fusion > CBP20207RBCR(E13)-ABL1(E2)_P210 Fusion

- 詳細(xì)內(nèi)容
CBP20207R | |
Format | RNA |
Description | Presence of a BCR-ABL1 fusion gene is necessary for the pathogenesis of CML. In up to 95% of cases, a t(9;22) (q34;q11) translocation results in the BCR-ABL1 fusion gene (Faderl et al. 1999). This translocation results in the Philadephia chromosome. In rare CML cases lacking the traditional t(9;22) translocation, other translocations result in the creation of the BCR-ABL1 fusion gene, which sometimes involve multiple chromosomes. |
Technical Data | |
Left Gene | BCR |
Right Gene | ABL1 |
Left Breakpoint | chr22:23631808:+(hg19) |
Right Breakpoint | chr9:133729451:+(hg19) |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | |
Storage | -80℃ |
Expiry | 12 months from the date of manufacture |